NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
申请人:Toyoshima Takahiro
公开号:US20090306396A1
公开(公告)日:2009-12-10
The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I):
wherein Y
1
represents N or C(R
4
); Y
2
represents N or C(R
5
); R
4
and R
5
independently represent an alkyl group, a hydrogen atom etc.; one of R
1
and R
2
represents an optionally substituted aryl group, an alkoxy group or an optionally substituted heterocyclic group; the other of R
1
and R
2
represents a haloalkyl group, a cyano group, a halogen atom etc.; and R
3
represents a 5-tetrazolyl group or a carboxy group, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the same as an active ingredient.
本发明涉及具有黄嘌呤氧化酶抑制和尿酸排泄作用的新化合物以及包含其作为活性成分的药物组合物。即,本发明涉及以下通式(I)所代表的含氮杂环化合物:
其中,Y1代表N或C(R4); Y2代表N或C(R5); R4和R5独立地代表烷基,氢原子等;R1和R2中的一个代表可选取代的芳基,烷氧基或可选取代的杂环基;另一个代表卤代烷基,氰基,卤素原子等;R3代表5-四唑基或羧基,以及其药学上可接受的盐和包含其作为活性成分的药物组合物。